Healthcare
Jazz Pharmaceuticals (JAZZ)
Jazz Pharmaceuticals stock analysis and opportunity scoring
$245.87
↑ +0.03%
Jazz Pharmaceuticals (JAZZ) at a glance
Jazz Pharmaceuticals (JAZZ) is a publicly traded company in the Healthcare - Drug Manufacturers - Specialty sector tracked by MKD Intelligence.
JAZZ last traded at $244.96 as of 2026-09-16.
MKD Intelligence assigns JAZZ a composite opportunity score of 49 out of 100, indicating mixed conditions across trend, momentum and volume factors.
The risk score for JAZZ is 49 out of 100 (moderate), where a higher number means greater expected volatility.
Price History
High
$260.23
Low
$240.07
Period
Sep 14 - Aug 14 (21d)
Hover for details • Scroll to zoom • Drag to pan • Double-click to reset
Recent News
No recent news available.
Upcoming Events
Data as of Sep 16
This platform provides market intelligence and educational information only. It does not constitute financial advice, and no information presented should be interpreted as a recommendation to buy, sell, or hold any security. Past performance and historical patterns do not guarantee future results.